New combo therapy shows promise for hard-to-treat liver cancer
NCT ID NCT07204327
First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 25 times
Summary
This study looks at how well a combination of two drugs (atezolizumab and bevacizumab) plus local treatments like chemo injections or radiation works for people with advanced liver cancer that can't be removed by surgery. Researchers will track over 1,100 patients to see how long they live and how safe the treatment is. The goal is to find better ways to control the disease and improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Zhongda Hospital, Southeast University
Nanjing, Jiangsu, 210009, China
Conditions
Explore the condition pages connected to this study.